Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | MAP2K1 |
| Variant | G301* |
| Impact List | nonsense |
| Protein Effect | unknown |
| Gene Variant Descriptions | MAP2K1 G301* results in a premature truncation of the Map2k1 protein at amino acid 301 of 393 (UniProt.org). G301* has not been characterized in the scientific literature and therefore, its effect on Map2k1 protein function is unknown (PubMed, Mar 2026). |
| Associated Drug Resistance | |
| Category Variants Paths |
MAP2K1 mutant MAP2K1 G301* |
| Transcript | NM_002755.4 |
| gDNA | chr15:g.66487233G>T |
| cDNA | c.901G>T |
| Protein | p.G301* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_002755.4 | chr15:g.66487233G>T | c.901G>T | p.G301* | RefSeq | GRCh38/hg38 |
| NM_002755.3 | chr15:g.66487233G>T | c.901G>T | p.G301* | RefSeq | GRCh38/hg38 |
| NM_002755 | chr15:g.66487233G>T | c.901G>T | p.G301* | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|